- Home
- MLP vs CDXC Comparison
MLP vs CDXC Comparison
Compare MLP & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- CDXC
- Stock Information
- Founded
- MLP 1909
- CDXC 1999
- Country
- MLP United States
- CDXC United States
- Employees
- MLP N/A
- CDXC N/A
- Industry
- MLP Real Estate
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- MLP Finance
- CDXC Health Care
- Exchange
- MLP Nasdaq
- CDXC Nasdaq
- Market Cap
- MLP 512.1M
- CDXC 546.9M
- IPO Year
- MLP 1972
- CDXC N/A
- Fundamental
- Price
- MLP $23.75
- CDXC $7.44
- Analyst Decision
- MLP
- CDXC Strong Buy
- Analyst Count
- MLP 0
- CDXC 2
- Target Price
- MLP N/A
- CDXC $8.00
- AVG Volume (30 Days)
- MLP 13.1K
- CDXC 3.0M
- Earning Date
- MLP 11-14-2024
- CDXC 10-31-2024
- Dividend Yield
- MLP N/A
- CDXC N/A
- EPS Growth
- MLP N/A
- CDXC N/A
- EPS
- MLP N/A
- CDXC 0.02
- Revenue
- MLP $12,196,000.00
- CDXC $91,668,000.00
- Revenue This Year
- MLP N/A
- CDXC $18.64
- Revenue Next Year
- MLP N/A
- CDXC $20.72
- P/E Ratio
- MLP N/A
- CDXC $383.52
- Revenue Growth
- MLP 34.84
- CDXC 9.95
- 52 Week Low
- MLP $14.03
- CDXC $1.32
- 52 Week High
- MLP $26.46
- CDXC $7.85
- Technical
- Relative Strength Index (RSI)
- MLP 54.73
- CDXC 71.43
- Support Level
- MLP $22.45
- CDXC $6.80
- Resistance Level
- MLP $24.13
- CDXC $7.85
- Average True Range (ATR)
- MLP 0.99
- CDXC 0.55
- MACD
- MLP 0.01
- CDXC 0.04
- Stochastic Oscillator
- MLP 53.65
- CDXC 82.25
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.